Marshall Wace’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.28M Buy
2024
Q4
Sell
2024
Q3
$253K Buy
2023
Q4
Sell
2023
Q3
$951K Buy
2023
Q2
Sell
2023
Q1
$1.06M Buy
2022
Q3
Sell
2022
Q2
$376K Sell
2022
Q1
$17.7M Buy
2021
Q2
Sell
2021
Q1
$1.86M Buy
2020
Q3
Sell
2020
Q2
$239K Sell
2020
Q1
$143K Buy
2014
Q3
Sell
2014
Q2
$2.79M Buy